AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Tumor-responsive copper-activated disulfiram for synergetic nanocatalytic tumor therapy

Hao Chen1,§, Xi Li1,§, Minfeng Huo3( ), Liying Wang4, Yu Chen2,3( ), Wei Chen1, Bailiang Wang1( )
School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
School of Life Sciences, Shanghai University, Shanghai 200444, China
State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China
Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China

§ Hao Chen and Xi Li contributed equally to this work.

Show Author Information

Graphical Abstract

Abstract

Exploring alternative biomedical use of traditional drugs in different disease models is highly important as it can reduce the cost of drug development and overcome several critical issues of traditional chemodrugs such as low chemotherapeutic efficiency, severe side effect, and drug resistance. Disulfiram (DSF), a clinically approved alcohol-aversion drug, was recently demonstrated to feature tumor-growth suppression effect along with the co-administration of Cu2+ species, but direct Cu2+ administration mode might cause severe toxicity originating from low Cu2+ accumulation into the tumor and nonspecific Cu2+ distribution-induced cytotoxicity. Based on the intriguing drug-delivery performance of nanoscale metal-organic frameworks (MOFs), we herein construct HKUST nMOFs as the Cu2+ self-supplying nanocarriers for efficient delivery of the DSF drug. The mildly acidic condition of tumor microenvironment initially triggered the release of Cu ions from HKUST nMOFs, which further reacted with the encapsulated DSF to form toxic Cu(DDTC)2 (activation) for tumor chemotherapy. Especially, during the Cu(DDTC)2 complexation, Cu+ species were formed concomitantly, triggering the intratumoral nanocatalytic therapy for the generation of reactive oxygen species to synergistically destroying the tumor cells/tissue. As a result, synergetic tumor-responsive chemotherapy and nanocatalytic therapy are enabled by DSF@HKUST nanodrugs, as demonstrated by the dominant anticancer efficacy with satisfied biocompatibility both in vitro and in vivo. The present work offers a sophisticated strategy for tumor-responsive nontoxic-to-toxic therapeutic with high biocompatibility.

Keywords

metal-organic frameworkschemotherapyFenton-like reactiondisulfiramtumor suppression

Electronic Supplementary Material

Download File(s)
12274_2020_3069_MOESM1_ESM.pdf (5.6 MB)

References

[1]
J. W. Xue,; Z. K. Zhao,; L. Zhang,; L. J. Xue,; S. Y. Shen,; Y. J. Wen,; Z. Y. Wei,; L. Wang,; L. Y. Kong,; H. B. Sun, et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 2017, 12, 692-700.
Crossref Google Scholar
[2]
P. A. Ma,; H. H. Xiao,; C. Yu,; J. H. Liu,; Z. Y. Cheng,; H. Q. Song,; X. Y. Zhang,; C. X. Li,; J. Q. Wang,; Z. Gu, et al. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett. 2017, 17, 928-937.
Crossref Google Scholar
[3]
L. L. Feng,; R. Xie,; C. Q. Wang,; S. L. Gai,; F. He,; D. Yang,; P. P. Yang,; J. Lin, Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS Nano 2018, 12, 11000-11012.
Crossref Google Scholar
[4]
J. Wang,; C. Luo,; C. L. Shan,; Q. C. You,; J. Y. Lu,; S. Elf,; Y. Zhou,; Y. Wen,; J. L. Vinkenborg,; J. Fan, et al. Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. Nat. Chem. 2015, 7, 968-979.
Crossref Google Scholar
[5]
R. R. Xing,; Q. L. Zou,; C. Q. Yuan,; L. Y. Zhao,; R. Chang,; X. H. Yan, Self-assembling endogenous biliverdin as a versatile near-infrared photothermal nanoagent for cancer theranostics. Adv. Mater. 2019, 31, 1900822.
Crossref Google Scholar
[6]
C. Holohan,; S. Van Schaeybroeck,; D. B. Longley,; P. G. Johnston, Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer 2013, 13, 714-726.
Crossref Google Scholar
[7]
H. Q. Cao,; Y. X. Wang,; X. Y. He,; Z. W. Zhang,; Q. Yin,; Y. Chen,; H. J. Yu,; Y. Z. Huang,; L. L. Chen,; M. H. Xu, et al. Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma. Mol. Pharm. 2015, 12, 922-931.
Crossref Google Scholar
[8]
G. R. Zheng,; R. R. Zhao,; A. X. Xu,; Z. C. Shen,; X. Chen,; J. W. Shao, Co-delivery of sorafenib and SiVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy. Eur. J. Pharm. Sci. 2018, 111, 492-502.
Crossref Google Scholar
[9]
P. P. Liang,; X. Y. Huang,; Y. Wang,; D. P. Chen,; C. J. Ou,; Q. Zhang,; J. J. Shao,; W. Huang,; X. C. Dong, Tumor-microenvironment-responsive nanoconjugate for synergistic antivascular activity and phototherapy. ACS Nano 2018, 12, 11446-11457.
Crossref Google Scholar
[10]
J. W. Tian,; J. F. Zhou,; Z. Shen,; L. Ding,; J. S. Yu,; H. X. Ju, A pH-activatable and aniline-substituted photosensitizer for near-infrared cancer theranostics. Chem. Sci. 2015, 6, 5969-5977.
Crossref Google Scholar
[11]
M. Valko,; C. J. Rhodes,; J. Moncol,; M. Izakovic,; M. Mazur, Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1-40.
Crossref Google Scholar
[12]
C. Zhang,; W. H. Chen,; L. H. Liu,; W. X. Qiu,; W. Y. Yu,; X. Z. Zhang, An O2 self-supplementing and reactive-oxygen-species-circulating amplified nanoplatform via H2O/H2O2 splitting for tumor imaging and photodynamic therapy. Adv. Funct. Mater. 2017, 27, 1700626.
Crossref Google Scholar
[13]
J. Qu,; X. Zhao,; P. X. Ma,; B. L. Guo, pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Acta Biomater. 2017, 58, 168-180.
Crossref Google Scholar
[14]
S. J. Tseng,; I. M. Kempson,; K. Y. Huang,; H. J. Li,; Y. C. Fa,; Y. C. Ho,; Z. X. Liao,; P. C. Yang, Targeting tumor microenvironment by bioreduction-activated nanoparticles for light-triggered virotherapy. ACS Nano 2018, 12, 9894-9902.
Crossref Google Scholar
[15]
L. S. Lin,; T. Huang,; J. B. Song,; X. Y. Ou,; Z. T. Wang,; H. Z. Deng,; R. Tian,; Y. J. Liu,; J. F. Wang,; Y. Liu, et al. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy. J. Am. Chem. Soc. 2019, 141, 9937-9945.
Crossref Google Scholar
[16]
B. Cvek, Nonprofit drugs as the salvation of the world’s healthcare systems: The case of antabuse (disulfiram). Drug Discov. Today 2012, 17, 409-412.
Crossref Google Scholar
[17]
X. P. Duan,; J. S. Xiao,; Q. Yin,; Z. W. Zhang,; H. J. Yu,; S. R. Mao,; Y. P. Li, Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 2013, 7, 5858-5869.
Crossref Google Scholar
[18]
X. G. Tao,; J. X. Gou,; Q. Y. Zhang,; X. Y. Tan,; T. Y. Ren,; Q. Yao,; B. Tian,; L. F. Kou,; L. Zhang,; X. Tang, Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles. Biomater. Sci. 2018, 6, 1869-1881.
Crossref Google Scholar
[19]
W. T. Song,; Z. H. Tang,; N. Shen,; H. Y. Yu,; Y. J. Jia,; D. W. Zhang,; J. Jiang,; C. L. He,; H. Y. Tian,; X. S. Chen, Combining disulfiram and poly(L-glutamic acid)-cisplatin conjugates for combating cisplatin resistance. J. Control. Release 2016, 231, 94-102.
Crossref Google Scholar
[20]
P. F. Zhao,; W. M. Yin,; A. H. Wu,; Y. S. Tang,; J. Y. Wang,; Z. Z. Pan,; T. T. Lin,; M. Zhang,; B. F. Chen,; Y. F. Duan, et al. Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of mannosylated albumin nanoparticles for drug-resistant cancer therapy. Adv. Funct. Mater. 2017, 27, 1700403.
Crossref Google Scholar
[21]
S. Bakthavatsalam,; M. L. Sleeper,; A. Dharani,; D. J. George,; T. Zhang,; K. J. Franz, Leveraging γ-glutamyl transferase to direct cytotoxicity of copper dithiocarbamates against prostate cancer cells. Angew. Chem., Int. Ed. 2018, 57, 12780-12784.
Crossref Google Scholar
[22]
L. Y. Xu,; J. L. Xu,; J. W. Zhu,; Z. J. Yao,; N. Yu,; W. Deng,; Y. Wang,; B. L. Lin, Universal anticancer Cu(DTC)2 discriminates between thiols and Zinc (II) thiolates oxidatively. Angew. Chem., Int. Ed. 2019, 131, 6131-6134.
Crossref Google Scholar
[23]
T. W. Loo,; M. C. Bartlett,; D. M. Clarke, Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein. Mol. Pharm. 2004, 1, 426-433.
Crossref Google Scholar
[24]
N. C. Yip,; I. S. Fombon,; P. Liu,; S. Brown,; V. Kannappan,; A. L. Armesilla,; B. Xu,; J. Cassidy,; J. L. Darling,; W. Wang, Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br. J. Cancer 2011, 104, 1564-1574.
Crossref Google Scholar
[25]
Z. Skrott,; M. Mistrik,; K. K. Andersen,; S. Friis,; D. Majera,; J. Gursky,; T. Ozdian,; J. Bartkova,; Z. Turi,; P. Moudry, et al. Alcohol-abuse drug disulfiram targets cancer via P97 segregase adaptor NPL4. Nature 2017, 552, 194-199.
Crossref Google Scholar
[26]
H. C. He,; E. Markoutsa,; J. Li,; P. S. Xu, Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly. Acta Biomater. 2018, 68, 113-124.
Crossref Google Scholar
[27]
A. Grubman,; A. R. White, Copper as a key regulator of cell signalling pathways. Expert Rev. Mol. Med. 2014, 16, e11.
Crossref Google Scholar
[28]
K. D. Lu,; T. Aung,; N. N. Guo,; R. Weichselbaum,; W. B. Lin, Nanoscale metal-organic frameworks for therapeutic, imaging, and sensing applications. Adv. Mater. 2018, 30, 1707634.
Crossref Google Scholar
[29]
W. Zhu,; G. L. Xiang,; J. Shang,; J. M. Guo,; B. Motevalli,; P. Durfee,; J. O. Agola,; E. N. Coker,; C. J. Brinker, Versatile surface functionalization of metal-organic frameworks through direct metal coordination with a phenolic lipid enables diverse applications. Adv. Funct. Mater. 2018, 28, 1705274.
Crossref Google Scholar
[30]
G. X. Lan,; K. Y. Ni,; Z. W. Xu,; S. S. Veroneau,; Y. Song,; W. B. Lin, Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy. J. Am. Chem. Soc. 2018, 140, 5670-5673.
Crossref Google Scholar
[31]
Y. Zhang,; F. M. Wang,; C. Q. Liu,; Z. Z. Wang,; L. H. Kang,; Y. Y. Huang,; K. Dong,; J. S. Ren,; X. G. Qu, Nanozyme decorated metal-organic frameworks for enhanced photodynamic therapy. ACS Nano 2018, 12, 651-661.
Crossref Google Scholar
[32]
K. Liang,; R. Ricco,; C. M. Doherty,; M. J. Styles,; S. Bell,; N. Kirby,; S. Mudie,; D. Haylock,; A. J. Hill,; C. J. Doonan, et al. Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules. Nat. Commun. 2015, 6, 7240.
Crossref Google Scholar
[33]
J. S. Xiao,; Y. X. Zhu,; S. Huddleston,; P. Li,; B. X. Xiao,; O. K. Farha,; G. A. Ameer, Copper metal-organic framework nanoparticles stabilized with folic acid improve wound healing in diabetes. ACS Nano 2018, 12, 1023-1032.
Crossref Google Scholar
[34]
J. S. Xiao,; S. Y. Chen,; J. Yi,; H. F. Zhang,; G. A. Ameer, A cooperative copper metal-organic framework-hydrogel system improves wound healing in diabetes. Adv. Funct. Mater. 2017, 27, 1604872.
Crossref Google Scholar
[35]
K. K. Sun,; L. Li,; X. L. Yu,; L. Liu,; Q. T. Meng,; F. Wang,; R. Zhang, Functionalization of mixed ligand metal-organic frameworks as the transport vehicles for drugs. J. Colloid Interface Sci. 2017, 486, 128-135.
Crossref Google Scholar
[36]
X. G. Wang,; Q. Cheng,; Y. Yu,; X. Z. Zhang, Controlled nucleation and controlled growth for size predicable synthesis of nanoscale metal-organic frameworks (MOFs): A general and scalable approach. Angew. Chem., Int. Ed. 2018, 57, 7836-7840.
Crossref Google Scholar
[37]
M. F. Huo,; L. Y. Wang,; Y. W. Wang,; Y. Chen,; J. L. Shi, Nanocatalytic tumor therapy by single-atom catalysts. ACS Nano 2019, 13, 2643-2653.
Crossref Google Scholar
[38]
C. Y. Zhang,; L. Yan,; X. Wang,; X. H. Dong,; R. Y. Zhou,; Z. J. Gu,; Y. L. Zhao, Tumor microenvironment-responsive Cu2(OH)PO4 nanocrystals for selective and controllable radiosentization via the X-ray-triggered fenton-like reaction. Nano Lett. 2019, 19, 1749-1757.
Crossref Google Scholar
[39]
D. J. Lewis,; P. Deshmukh,; A. A. Tedstone,; F. Tuna,; P. O’Brien, On the interaction of copper(II) with disulfiram. Chem. Commun. 2014, 50, 13334-13337.
Crossref Google Scholar
[40]
W. C. Wu,; L. D. Yu,; Q. Z. Jiang,; M. F. Huo,; H. Lin,; L. Y. Wang,; Y. Chen,; J. L. Shi, Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. J. Am. Chem. Soc. 2019, 141, 11531-11539.
Crossref Google Scholar
[41]
D. Mao,; W. B. Wu,; S. D. Ji,; C. Chen,; F. Hu,; D. L. Kong,; D. Ding,; B. Liu, Chemiluminescence-guided cancer therapy using a chemiexcited photosensitizer. Chem 2017, 3, 991-1007.
Crossref Google Scholar
[42]
X. Zhen,; C. W. Zhang,; C. Xie,; Q. Q. Miao,; K. L. Lim,; K. Y. Pu, Intraparticle energy level alignment of semiconducting polymer nanoparticles to amplify chemiluminescence for ultrasensitive in vivo imaging of reactive oxygen species. ACS Nano 2016, 10, 6400-6409.
Crossref Google Scholar
Nano Research
Volume 14 Issue 1,
January 2021
Pages 205-211
DOI: 10.1007/s12274-020-3069-1
Cite this article:
Chen H, Li X, Huo M, et al. Tumor-responsive copper-activated disulfiram for synergetic nanocatalytic tumor therapy. Nano Research, 2021, 14(1): 205-211. https://doi.org/10.1007/s12274-020-3069-1
Topics:
BiocompatibilityChemotherapy Controlled drug deliveryCytotoxicityOrganic frameworks OrganometallicsTargeted drug deliveryTumors

1024

Views

43

Crossref

0

Web of Science

41

Scopus

1

CSCD

Altmetrics
Received: 19 March 2020
Revised: 18 August 2020
Accepted: 22 August 2020
Published: 05 January 2021
© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature
Return